Ton de Vries

3.8k total citations
35 papers, 1.6k citations indexed

About

Ton de Vries is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ton de Vries has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 24 papers in Cardiology and Cardiovascular Medicine and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ton de Vries's work include Coronary Interventions and Diagnostics (26 papers), Cardiac Imaging and Diagnostics (17 papers) and Cardiac Valve Diseases and Treatments (10 papers). Ton de Vries is often cited by papers focused on Coronary Interventions and Diagnostics (26 papers), Cardiac Imaging and Diagnostics (17 papers) and Cardiac Valve Diseases and Treatments (10 papers). Ton de Vries collaborates with scholars based in Netherlands, United Kingdom and United States. Ton de Vries's co-authors include Patrick W. Serruys, Stephan Windecker, Christos V. Bourantas, Scot Garg, Friedrich W. Mohr, Yao‐Jun Zhang, Keith D. Dawkins, Héctor M. García‐García, Vasim Farooq and Yoshinobu Onuma and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Ton de Vries

35 papers receiving 1.6k citations

Peers

Ton de Vries
Michael Magro Netherlands
Ton de Vries
Citations per year, relative to Ton de Vries Ton de Vries (= 1×) peers Michael Magro

Countries citing papers authored by Ton de Vries

Since Specialization
Citations

This map shows the geographic impact of Ton de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ton de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ton de Vries more than expected).

Fields of papers citing papers by Ton de Vries

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ton de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ton de Vries. The network helps show where Ton de Vries may publish in the future.

Co-authorship network of co-authors of Ton de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Ton de Vries. A scholar is included among the top collaborators of Ton de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ton de Vries. Ton de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spitzer, Ernest, Eugène McFadden, Pascal Vranckx, et al.. (2019). Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials. JACC: Cardiovascular Interventions. 12(9). 805–819. 17 indexed citations
2.
Spitzer, Ernest, Eugène McFadden, Pascal Vranckx, et al.. (2018). Defining Staged Procedures for Percutaneous Coronary Intervention Trials. JACC: Cardiovascular Interventions. 11(9). 823–832. 11 indexed citations
3.
Spitzer, Ernest, Ton de Vries, Rafael Cavalcante, et al.. (2017). Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials. JACC: Cardiovascular Interventions. 10(7). 658–666. 5 indexed citations
4.
Ghione, Matteo, Joanna J. Wykrzykowska, Stephan Windecker, et al.. (2016). Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial. Cardiology Journal. 23(6). 626–636. 4 indexed citations
5.
Sakellarios, Antonis I., Christos V. Bourantas, Stella‐Lida Papadopoulou, et al.. (2016). Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study. European Heart Journal - Cardiovascular Imaging. 18(1). 11–18. 33 indexed citations
6.
Ridder, Maria de, Ton de Vries, & Lidia R. Arends. (2015). Getting maximum information out of a continuous outcome: applying linear regression. EuroIntervention. 11(6). 718–722. 1 indexed citations
7.
Zhang, Yao‐Jun, Javaid Iqbal, Carlos M. Campos, et al.. (2014). Prognostic Value of Site SYNTAX Score and Rationale for Combining Anatomic and Clinical Factors in Decision Making. Journal of the American College of Cardiology. 64(5). 423–432. 32 indexed citations
9.
Farooq, Vasim, Patrick W. Serruys, Yao‐Jun Zhang, et al.. (2013). Short-Term and Long-Term Clinical Impact of Stent Thrombosis and Graft Occlusion in the SYNTAX Trial at 5 Years. Journal of the American College of Cardiology. 62(25). 2360–2369. 32 indexed citations
10.
Farooq, Vasim, Patrick W. Serruys, Pascal Vranckx, et al.. (2013). Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation. International Journal of Cardiology. 168(6). 5287–5292. 13 indexed citations
12.
Farooq, Vasim, Yvonne Vergouwe, Lorenz Räber, et al.. (2012). COMBINED ANATOMICAL AND CLINICAL FACTORS FOR THE RISK STRATIFICATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: THE LOGISTIC CLINICAL SYNTAX SCORE. Journal of the American College of Cardiology. 59(13). E1374–E1374. 1 indexed citations
14.
Wykrzykowska, Joanna J., Scot Garg, Ton de Vries, et al.. (2010). VALUE OF THE SYNTAX SCORE (SX) FOR RISK ASSESSMENT IN THE “ALL-COMERS” POPULATION OF THE RANDOMIZED MULTICENTER LEADERS TRIAL.. Journal of the American College of Cardiology. 55(10). A191.E1787–A191.E1787. 10 indexed citations
15.
Gómez‐Lara, Josep, Héctor M. García‐García, Yoshinobu Onuma, et al.. (2010). A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents. JACC: Cardiovascular Interventions. 3(11). 1190–1198. 79 indexed citations
16.
Wykrzykowska, Joanna J., Scot Garg, Chrysafios Girasis, et al.. (2010). Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. Journal of the American College of Cardiology. 56(4). 272–277. 172 indexed citations
17.
Wykrzykowska, Joanna J., Patrick W. Serruys, Yoshinobu Onuma, et al.. (2009). Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer. JACC: Cardiovascular Interventions. 2(9). 861–870. 39 indexed citations
18.
Wykrzykowska, Joanna J., Lorenz Räber, Ton de Vries, et al.. (2009). Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. EuroIntervention. 5(3). 310–317. 7 indexed citations
19.
Waard, F. de, et al.. (1993). A feasibility study on weight reduction in obese postmenopausal breast cancer patients. European Journal of Cancer Prevention. 2(3). 233–238. 61 indexed citations
20.
Kuipers, H., et al.. (1988). Comparison of heart rate as a non-invasive determinant of anaerobic threshold with the lactate threshold when cycling. European Journal of Applied Physiology. 58(3). 303–306. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026